Mounjaro (tirzepatide) goes up to 15 mg per week, which is the maximum FDA-approved dose. The medication comes in six different strengths, starting at 2.5 mg and increasing in 2.5 mg steps: 2.5, 5, 7.5, 10, 12.5, and 15 mg. Each strength is a single-dose, pre-filled pen injected once weekly.
How the Dose Increases Over Time
Everyone starts at the same place: 2.5 mg once a week for at least four weeks. This starting dose is designed to let your body adjust to the medication rather than to deliver the full therapeutic effect. After those first four weeks, the dose typically moves up to 5 mg.
From there, each increase is another 2.5 mg step, and you need to stay on each dose for a minimum of four weeks before moving up again. That means reaching the maximum 15 mg dose takes at least 20 weeks if you move up at every opportunity. In practice, many people take longer because their prescriber may hold them at a mid-range dose that’s working well enough.
Not everyone needs to reach 15 mg. The dose is adjusted based on how your blood sugar or weight responds, and some people get good results at 7.5 or 10 mg. The six available strengths exist specifically so the dose can be tailored rather than forced to the top.
What the 15 mg Dose Achieves
Clinical trials tested the 15 mg dose extensively in people with type 2 diabetes. Across multiple large studies, patients on the maximum dose saw their A1C (a measure of average blood sugar over roughly three months) drop by 2.1 to 2.4 percentage points from where they started. For context, that’s a substantial reduction. Someone starting with an A1C of 8.5% could potentially bring it down close to the normal range.
The pattern across trials was consistent. In one 40-week study of nearly 470 patients on 15 mg, A1C fell by 2.3%. A 52-week study of about 360 patients showed a 2.1% drop. Another 52-week trial of roughly 340 patients saw a 2.4% reduction. These results were measured on top of other diabetes medications patients were already taking.
Side Effects at Higher Doses
Gastrointestinal side effects are the most common issue with Mounjaro at any dose, and they become more likely as the dose goes up. In clinical trials, up to 22% of people taking Mounjaro experienced nausea, meaning roughly 1 in 5. Up to 1 in 10 reported vomiting. Diarrhea affected about 12% to 17% of participants.
The gradual dose escalation exists partly to manage this. Jumping straight to a high dose would cause more intense nausea and stomach upset. By spending at least four weeks at each level, your body has time to adjust before the next increase. Many people find that side effects peak during the first few days after a dose increase and then ease up. If side effects remain difficult at a given dose, staying at that level longer (or not increasing further) is a common approach.
Can the Dose Go Higher Than 15 mg?
Right now, 15 mg is the ceiling. No approved formulation goes beyond it. Eli Lilly has registered a clinical trial investigating higher doses of tirzepatide (the active ingredient in Mounjaro) in people with type 2 diabetes and obesity, but the specific milligram amounts being tested haven’t been publicly disclosed yet, and no higher dose is available or approved.
If you’ve reached 15 mg and aren’t seeing the results you expected, the options are typically to ensure you’ve been on the dose long enough for full effect, to revisit diet and activity, or to explore adding or switching medications. The 15 mg dose is the most the medication can currently offer.
The Full Dose Ladder at a Glance
- 2.5 mg: starting dose, taken for at least 4 weeks
- 5 mg: first therapeutic increase
- 7.5 mg: second increase
- 10 mg: third increase
- 12.5 mg: fourth increase
- 15 mg: maximum approved dose
Each step requires a minimum of four weeks before the next increase. Every dose comes as its own pre-filled pen, so you don’t combine pens or adjust the injection volume yourself.